These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 4362501)

  • 1. Proceedings: Influence of halothane on mortality from murine hepatitis virus (MHV3).
    Moudgil GC
    Br J Anaesth; 1973 Dec; 45(12):1236. PubMed ID: 4362501
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of a trypsin and kallikrein inactivator in MHV3 induced experimental hepatitis in mice].
    Manganaro M
    Arch Ital Sci Med Trop Parassitol; 1968; 49(11):319-26. PubMed ID: 4311435
    [No Abstract]   [Full Text] [Related]  

  • 3. Mouse hepatitis virus (MHV3) infection in chronic murine schistosomiasis mansoni.
    Warren KS; Rosenthal MS; Domingo EO
    Bull N Y Acad Med; 1969 Feb; 45(2):211-24. PubMed ID: 4308302
    [No Abstract]   [Full Text] [Related]  

  • 4. Some aspects on the transmission of hepatitis B antigen; model experiments by mosquitoes with murine hepatitis virus.
    Ishii A; Yago A; Nariuchi H; Shirasaka A; Wada Y
    Jpn J Exp Med; 1974 Dec; 44(6):495-501. PubMed ID: 4156373
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of cyclophosphamide on the genetic resistance of C 3 H mice to mouse hepatitis virus.
    Willenborg DO; Shah KV; Bang FB
    Proc Soc Exp Biol Med; 1973 Mar; 142(3):762-6. PubMed ID: 4348090
    [No Abstract]   [Full Text] [Related]  

  • 6. Studies on the mechanism of destruction of lymphoid tissue in murine hepatitis virus (MHV3) infection. I. Selective prevention of lymphoid necrosis by cortisone and puromycin.
    Hirano T; Ruebner BH
    Lab Invest; 1966 Jan; 15(1 Pt 2):270-82. PubMed ID: 4286629
    [No Abstract]   [Full Text] [Related]  

  • 7. [Absence of change in the concentration of the hepatitis virus inhibitor MHV 3 (Piazza's factor) in mice treated with a immunosuppressive drug (azathioprine)].
    Visconti M; De Marco F; Lista D; Pane G; Squame G
    Boll Soc Ital Biol Sper; 1972 Apr; 48(8):181-3. PubMed ID: 4341593
    [No Abstract]   [Full Text] [Related]  

  • 8. Increased susceptibility to mouse hepatitis virus 3 of peritoneal macrophages exposed to dieldrin.
    Krzystyniak K; Hugo P; Flipo D; Fournier M
    Toxicol Appl Pharmacol; 1985 Sep; 80(3):397-408. PubMed ID: 2994259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mouse Hepatitis Virus Infection Induces a Toll-Like Receptor 2-Dependent Activation of Inflammatory Functions in Liver Sinusoidal Endothelial Cells during Acute Hepatitis.
    Bleau C; Filliol A; Samson M; Lamontagne L
    J Virol; 2016 Oct; 90(20):9096-113. PubMed ID: 27489277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mouse hepatitis virus 3 pathogenicity expressed by a lytic viral infection in bone marrow 14.8+ mu+ B lymphocyte subpopulations.
    Jolicoeur P; Lamontagne L
    J Immunol; 1989 Dec; 143(11):3722-30. PubMed ID: 2555417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mouse hepatitis virus 3 replication in T and B lymphocytes correlate with viral pathogenicity.
    Lamontagne L; Descoteaux JP; Jolicoeur P
    J Immunol; 1989 Jun; 142(12):4458-65. PubMed ID: 2542412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Response of nude mice to a mouse hepatitis virus isolated from a wasting nude mouse.
    Tamura T; Ueda K; Hirano N; Fujiwara K
    Jpn J Exp Med; 1976 Feb; 46(1):19-30. PubMed ID: 180312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathogenicity of murine hepatitis virus recovered from infant Swiss mice.
    Nelson JB
    Proc Soc Exp Biol Med; 1965 Oct; 120(1):41-4. PubMed ID: 4285241
    [No Abstract]   [Full Text] [Related]  

  • 14. [On the transfer of infection in mouse hepatitis].
    Barinskiĭ IF; Bolotovskiĭ VM; Anan'ev VA
    Vopr Virusol; 1965; 10(1):79-83. PubMed ID: 4286215
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunopathology of mouse hepatitis virus type 3 infection. III. Clinical and virologic observation of a persistent viral infection.
    Prévost CL; Virelizier JL; Dupuy JM
    J Immunol; 1975 Sep; 115(3):640-3. PubMed ID: 168262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Entry of mouse hepatitis virus 3 into cells.
    Krzystyniak K; Dupuy JM
    J Gen Virol; 1984 Jan; 65 ( Pt 1)():227-31. PubMed ID: 6319570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The infection of mice with the mouse hepatitis virus (MHV 3). I. Analysis of several experimental data from the view point of the single hit theory].
    Degen L; Varone GL
    Arch Gesamte Virusforsch; 1969; 26(1):21-32. PubMed ID: 4306364
    [No Abstract]   [Full Text] [Related]  

  • 18. Lymphoid necrosis in the mouse spleen produced by mouse hepatitis virus (MHV3): an electron-microscopic study.
    Biggart JD; Ruebner BH
    J Med Microbiol; 1970 Nov; 3(4):627-32. PubMed ID: 4323489
    [No Abstract]   [Full Text] [Related]  

  • 19. Pathogenicity of mouse hepatitis virus for mice depending upon host age and route of infection.
    Hirano N; Takenaka S; Fujiwara K
    Jpn J Exp Med; 1975 Aug; 45(4):285-92. PubMed ID: 171465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphokine release as measurement of anti-mouse hepatitis virus type 3 (MHV3) cellular reactions in various mouse lines exhibiting differential susceptibilities to MHV3-induced paralysis.
    Mansour S; Mercier G; Oth D
    Acta Virol; 1990 Sep; 34(5):423-32. PubMed ID: 1981453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.